Cytogenix (fka CYGX)

[schrodbox]

It is a needless risk. The company gains no benefit from being listed there. Companies like CYGX are primary targets for naked shorting on that exchange and I suspect it might already be happening. The inexplicable drop in PPS , especially after the good sepsis results and the herpes trials beginning in India, and the emergence of an obviously paid basher are two good signs that it is. I sincerely hope we get off that exchange before the company has to take drastic measures to try to stop the drop in PPS.

It starts as a spiral of downward pressures on the share prices and ends with a reverse stock split and the company possibly going out of business.

Why take that chance for no benefit?